Fernando Perez-Ruiz

Has grant

Associate Professor

Universidad del País Vasco Facultad de Farmacia

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Fernando Perez-Ruiz is an Associate Professor at Universidad del Pais Vasco Facultad de Medicina y Enfermería in Spain. His research primarily focuses on gout and related arthropathies, as evidenced by his recent publications on innovative treatment approaches, genetic factors in arthritis severity, and guidelines for imaging in clinical practice. Additionally, he has contributed to studies on the transition to biosimilar medications in rheumatoid arthritis patients.

Recent Grants

Grant: Close

Cruces Gout Cohort

Open Date:

Close Date:

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (16)

Amy Fuller

University of Nottingham

UNITED KINGDOM

Fernando Perez-Ruiz

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (23)

Correction: The ‘FebBenz’ approach for severe difficult-to-treat gout

The ‘FebBenz’ approach for severe difficult-to-treat gout

Transition from reference adalimumab to biosimilar SB5 in patients with rheumatoid arthritis: sub-analysis of Spanish patients in the PROPER study

The 15th European Crystal Network (ECN) Workshop—2024 ECN Abstract Proceedings

Prevalence and factors associated to calcium pyrophosphate arthritis in patients with gout

Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers

2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice

A genome-wide association analysis reveals new pathogenic pathways in gout

Utility of dimethylsulfoxide to preserve synovial fluid samples for microcrystal detection and identification

Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

Mechanisms and rationale for uricase use in patients with gout

Towards a more ambitious uricemia target to improve joint and cardiovascular outcomes in gout

Opening editorial for exploration in musculoskeletal diseases

Association of mutations in hemochromatosis genes with clinical severity of calcium pyrophosphate arthritis

Prevalence and factors associated to diffuse idiopathic skeletal hyperostosis in gout

Gout. What's up doc?

Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables.

Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases.

Identifying potential classification criteria for calcium pyrophosphate deposition disease (CPPD): Item generation and item reduction.

Which factors predict discordance between a patient and physician on a gout flare?

High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?

Collaborators (16)

Amy Fuller

Geraldine McCarthy

Hongbo Liu

Ann Rosenthal

Abhishek Abhishek

Till Uhlig

Mariano Andrés

Burak Kundakci

Tony Merriman

Francisco J. Blanco-García

Riku Takei

Tristan Pascart

Edward Roddy

Thomas MacDonald

Tuhina Neogi

Amanda Phipps-Green

Make your next move.